147 related articles for article (PubMed ID: 21943802)
1. A framework for the evaluation of "value" and cost-effectiveness in the management of critical limb ischemia.
Barshes NR; Belkin M;
J Am Coll Surg; 2011 Oct; 213(4):552-66.e5. PubMed ID: 21943802
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of revascularization for limb preservation in patients with marginal functional status.
Barshes NR; Kougias P; Ozaki CK; Pisimisis G; Bechara CF; Henson HK; Belkin M
Ann Vasc Surg; 2014 Jan; 28(1):10-7. PubMed ID: 24332257
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of revascularization for limb preservation in patients with end-stage renal disease.
Barshes NR; Kougias P; Ozaki CK; Goodney PP; Belkin M
J Vasc Surg; 2014 Aug; 60(2):369-374.e1. PubMed ID: 24657067
[TBL] [Abstract][Full Text] [Related]
4. Surgery for limb threatening ischaemia: a reappraisal of the costs and benefits.
Johnson BF; Evans L; Drury R; Datta D; Morris-Jones W; Beard JD
Eur J Vasc Endovasc Surg; 1995 Feb; 9(2):181-8. PubMed ID: 7627652
[TBL] [Abstract][Full Text] [Related]
5. Tibial angioplasty for limb salvage in high-risk patients and cost analysis.
Werneck CC; Lindsay TF
Ann Vasc Surg; 2009; 23(5):554-9. PubMed ID: 19632085
[TBL] [Abstract][Full Text] [Related]
6. Determinants of Long-Term Outcomes and Costs in the Management of Critical Limb Ischemia: A Population-Based Cohort Study.
Mustapha JA; Katzen BT; Neville RF; Lookstein RA; Zeller T; Miller LE; Jaff MR
J Am Heart Assoc; 2018 Aug; 7(16):e009724. PubMed ID: 30369325
[TBL] [Abstract][Full Text] [Related]
7. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis.
Forbes JF; Adam DJ; Bell J; Fowkes FG; Gillespie I; Raab GM; Ruckley CV; Bradbury AW;
J Vasc Surg; 2010 May; 51(5 Suppl):43S-51S. PubMed ID: 20435261
[TBL] [Abstract][Full Text] [Related]
8. Cost-efficacy issues in the treatment of peripheral vascular disease: primary amputation or revascularization for limb-threatening ischemia.
Perler BA
J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):111S-115S. PubMed ID: 8770853
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Drug-Eluting Stents for Infrapopliteal Lesions in Patients with Critical Limb Ischemia: The PADI Trial.
Wakkie T; Konijn LCD; van Herpen NPC; Maessen MFH; Spreen MI; Wever JJ; Statius van Eps RG; Veger HT; van Dijk LC; Mali WPTM; van Overhagen H
Cardiovasc Intervent Radiol; 2020 Mar; 43(3):376-381. PubMed ID: 31807849
[TBL] [Abstract][Full Text] [Related]
10. The costs of surgery for limb-threatening ischemia.
Mackey WC; McCullough JL; Conlon TP; Shepard AD; Deterling RA; Callow AD; O'Donnell TF
Surgery; 1986 Jan; 99(1):26-35. PubMed ID: 3079928
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of the treatments for critical limb ischemia in the elderly population.
Peters CML; de Vries J; Redeker S; Timman R; Eijck GV; Steunenberg SL; Verbogt N; Ho GH; van Busschbach JJ; van der Laan L
J Vasc Surg; 2019 Aug; 70(2):530-538.e1. PubMed ID: 30922757
[TBL] [Abstract][Full Text] [Related]
12. 24-carat gold, 14-carat gold, or platinum standards in the treatment of critical limb ischemia: bypass surgery or endovascular intervention?
Allie DE; Hebert CJ; Ingraldi A; Patlola RR; Walker CM
J Endovasc Ther; 2009 Feb; 16 Suppl 1():I134-46. PubMed ID: 19317578
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness in the contemporary management of critical limb ischemia with tissue loss.
Barshes NR; Chambers JD; Cohen J; Belkin M;
J Vasc Surg; 2012 Oct; 56(4):1015-24.e1. PubMed ID: 22854267
[TBL] [Abstract][Full Text] [Related]
14. [Cost-benefit analysis of saving the leg].
Bruijnen H; Loeprecht H
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():617-9. PubMed ID: 2577606
[TBL] [Abstract][Full Text] [Related]
15. Cost of treating advanced leg ischemia. Bypass graft vs primary amputation.
Raviola CA; Nichter LS; Baker JD; Busuttil RW; Machleder HI; Moore WS
Arch Surg; 1988 Apr; 123(4):495-6. PubMed ID: 3348741
[TBL] [Abstract][Full Text] [Related]
16. [Vascular surgery in order to save the lower limb].
Luther M
Duodecim; 1997; 113(20):2035-43. PubMed ID: 10892099
[No Abstract] [Full Text] [Related]
17. A cost-effectiveness analysis of infrainguinal bypass in the absence of great saphenous vein conduit.
Barshes NR; Ozaki CK; Kougias P; Belkin M
J Vasc Surg; 2013 Jun; 57(6):1466-70. PubMed ID: 23395205
[TBL] [Abstract][Full Text] [Related]
18. Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft.
Sachs T; Pomposelli F; Hamdan A; Wyers M; Schermerhorn M
J Vasc Surg; 2011 Oct; 54(4):1021-1031.e1. PubMed ID: 21880457
[TBL] [Abstract][Full Text] [Related]
19. The burden of critical limb ischemia: a review of recent literature.
Duff S; Mafilios MS; Bhounsule P; Hasegawa JT
Vasc Health Risk Manag; 2019; 15():187-208. PubMed ID: 31308682
[TBL] [Abstract][Full Text] [Related]
20. The economics of femorocrural reconstruction for critical leg ischemia with and without autologous vein.
Cheshire NJ; Wolfe JH; Noone MA; Davies L; Drummond M
J Vasc Surg; 1992 Jan; 15(1):167-74; discussion 174-5. PubMed ID: 1728675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
